Where Does Wall Street Think Sutro Biopharma Inc (STRO) Stock Will Go?

Monday, May 09, 2022 09:50 AM | InvestorsObserver Analysts

Mentioned in this article

Analysts who follow Sutro Biopharma Inc (STRO) on average expect it to add 541.53% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns STRO an Analyst Ranking of 72, which means it ranks higher than 72 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating STRO a Strong Buy today. Find out what this means to you and get the rest of the rankings on STRO!
See Full STRO Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Sutro Biopharma Inc Stock Today?

Sutro Biopharma Inc (STRO) stock is trading at $5.04 as of 9:47 AM on Monday, May 9, a drop of -$0.68, or -11.89% from the previous closing price of $5.72. The stock has traded between $4.98 and $5.84 so far today. Volume today is below average. So far 25,926 shares have traded compared to average volume of 459,918 shares. Click Here to get the full Stock Report for Sutro Biopharma Inc stock.

Share this article:

Related Articles